Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
follicular lymphoma
Pharma
EU signs off on Regeneron's T-cell engager for 2 blood cancers
Five months after the FDA rejected Regeneron’s bid for approval of odronextamab, the European Union has signed off on the treatment.
Kevin Dunleavy
Aug 26, 2024 10:35am
Incyte eyes label expansion for Monjuvi after phase 3 win
Aug 16, 2024 11:23am
AbbVie's Epkinly follows Roche's Lunsumio into FL
Jun 27, 2024 10:21am
BMS' Breyanzi bags FDA nod to treat follicular lymphoma
May 16, 2024 10:56am
As Imbruvica fails, Brukinsa wins FDA nod in follicular lymphoma
Mar 7, 2024 4:08pm
ASH: Roche offers glimpse at Columvi-Polivy combo in DLBCL
Dec 11, 2023 7:00am
